Atom Investors’s Gilead Sciences GILD Stock Holding History

Atom Investors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.67M	Buy	+29,028	New	+$3.82M	0.33%	43
2025 Q4	–	Sell	-26,398	Closed	-$2.93M	–	672
2025 Q3	$2.93M	Buy	+26,398	New	+$3M	0.22%	126
2025 Q2	–	Sell	-11,837	Closed	-$1.33M	–	679
2025 Q1	$1.33M	Buy	+11,837	New	+$1.22M	0.16%	170
2024 Q4	–	Sell	-12,942	Closed	-$1.09M	–	547
2024 Q3	$1.09M	Buy	+12,942	New	+$988K	0.11%	245
2023 Q4	–	Sell	-19,158	Closed	-$1.44M	–	494
2023 Q3	$1.44M	Buy	19,158 +14,320	+296%	+$1.1M	0.33%	94
2023 Q2	$373K	Buy	+4,838	New	+$386K	0.14%	152
2021 Q4	–	Sell	-11,186	Closed	-$781K	–	323
2021 Q3	$781K	Buy	+11,186	New	+$786K	0.06%	159
2021 Q2	–	Sell	-4,600	Closed	-$297K	–	275
2021 Q1	$297K	Buy	+4,600	New	+$297K	0.05%	190
2020 Q1	–	Sell	-51,897	Closed	-$3.37M	–	345
2019 Q4	$3.37M	Sell	51,897 -60,460	-54%	-$3.94M	0.28%	100
2019 Q3	$7.12M	Buy	+112,357	New	+$7.34M	0.49%	71
2019 Q2	–	Sell	-92,482	Closed	-$6.01M	–	492
2019 Q1	$6.01M	Buy	+92,482	New	+$6.15M	0.51%	63

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atom Investors's GILD Position: Q2 2026 in Review

Atom Investors opened a new position in Gilead Sciences (GILD) in Q2 2026: 29,028 shares worth $3.67M. The stake represents 0.33% of the portfolio and ranks #43 among its holdings. This is a return to the name: Atom Investors previously reported a position in GILD as recently as Q3 2025.

Atom Investors first reported a position in GILD in Q1 2019 and has held it in 11 quarters since. The position peaked at $7.12M in Q3 2019. 2,273 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Atom Investors held 29,028 shares of Gilead Sciences worth $3.67M as of Q2 2026.
Gilead Sciences was a new Atom Investors position in Q2 2026.
Gilead Sciences made up 0.33% of Atom Investors's portfolio in Q2 2026, its #43 holding.
Atom Investors first reported a position in Gilead Sciences in Q1 2019 and has held it in 11 quarters since.
Atom Investors's Gilead Sciences position peaked at $7.12M in Q3 2019.
2,273 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.